INITIAL RESEARCH CLINICAL CHARACTERISTICS AND DISEASE MODEL OF OUTPATIENTS WITH A HISTORY OF SARS-COV-2 INFECTION AT MEDICAL FACILITIES OF THE MEDLATEC GROUP

Nguyễn Anh Trí1, Nguyễn Thị Kim Len2, Bùi Văn Long1, Nguyễn Thị Huyền1, Vũ Thị Tuyền1, Nguyễn Thị Nhung1, Hoàng Thị Hương Trà1,, Dương Thị Thủy2, Nguyễn Thị Thu Hương3, Lê Thị Hoài Thanh3, Phạm Tiến Thọ3, Lê Thị Hoàng3
1 MEDLTEC Group
2 MEDLATEC General Hospital
3 MEDLATEC General Hospital at Thanh Xuan, Tay Ho, Vinh Phuc, Thanh Hoa

Main Article Content

Abstract

Objectives: To describe clinical characteristics and disease model of outpatients with a history of SARS-CoV-2 infection at medical facilities of MEDLATEC Group. Subjects and methods: A cross-sectional descriptive study was carried out in 1040 outpatients at 5 medical facilities of MEDLATEC Group. Results: Females accounted for 55.67%. The mean age of the study group was 33.01 ± 17.91 (years old). Most of the patients at a prolonged stage of COVID-19 (75.0%) had received at least 2 doses of COVID-19 vaccine (83.36%). There were 28.97% patients with underlying disease before SARS-CoV-2 infection, the highest were overweight and obesity (7.98%), hypertension (5.67%). 72.79% of patients had at least 1 clinical symptom, the most common were dry cough (29.81%), fatigue (21.06%), cough with phlegm (15.29%), chest pain, chest tightness (13.56%), short of breath (12.88%). The most common group of respiratory diseases is in all age groups. Then there is the pathology of neurology, cardiology in adults and the elderly, gastroenterology in children. Psychiatrics are only seen in adults and the elderly, but not in children. Conclusions: Indentifying the disease model helps managers to flexibly change their patient access strategy, in order to properly allocate medical resources to provide the best medical service.

Article Details

References

1. COVID-19 rapid guideline: managing the longterm effects of COVID-19) https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 ;. .
2. Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. (2021). More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep, 11(1), 16144.
3. Augustin M., Schommers P., Stecher M., et al. (2021). Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health - Eur, 6, 100122.
4. Davis H.E., Assaf G.S., McCorkell L., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine, 38.
5. Carfì A., Bernabei R., Landi F., et al. (2020). Persistent Symptoms in Patients After Acute COVID-19. JAMA, 324(6), 603–605.
6. van Kessel S.A.M., Olde Hartman T.C., Lucassen P., et al. (2022). Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pr, 39(1), 159–167.
7. Ghosn J., Piroth L., Epaulard O., et al. (2021). Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect, 27(7), 1041.e1-1041.e4.
8. Bellan M., Soddu D., Balbo P.E., et al. (2021). Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open, 4(1), e2036142.